Home Usefulness of transcutaneous bilirubin assessment measured in non-photo-exposed skin to guide the length of phototherapy: an observational study
Article
Licensed
Unlicensed Requires Authentication

Usefulness of transcutaneous bilirubin assessment measured in non-photo-exposed skin to guide the length of phototherapy: an observational study

  • Abdón Castro , Carlos Zozaya ORCID logo EMAIL logo , Mª Teresa Cuesta , Marina González , Gema Villar and Andrés Alcaraz
Published/Copyright: April 18, 2019

Abstract

Background

Transcutaneous bilirubinometers are a non-invasive tool to estimate serum bilirubin. However, once on phototherapy (PHT) and after PHT, its usefulness is precluded. The objective of this study was to prove the hypothesis that transcutaneous bilirubin (TcB) assessment in a covered skin area during PHT could be used to guide the duration of PHT in term and moderate-late preterm infants with non-isoimmune hyperbilirubinemia.

Methods

A small area of parasternal skin was covered before starting on PHT. Total serum and TcB (both in exposed and non-exposed areas) were determined before starting treatment, every 12 h once on PHT and 12 h after its discontinuation. Pearson’s correlation coefficient and paired mean differences between TcB and total serum bilirubin (TSB) were calculated. Bland-Altman plots were obtained. The percentage of correct treatment decisions made based on non-exposed TcB values was calculated.

Results

During PHT, there was a relatively good correlation between TSB and non-exposed TcB (0.74) estimates, in contrast to exposed TcB estimates (0.52). However, even when comparing non-exposed TcB with TSB, there was a wide range of agreement limits (−3.8 to 4.6 mg/dL). Decisions based on non-exposed TcB values would have been incorrect in 26.6% of the cases.

Conclusion

Although there is a relatively strong correlation between total serum and TcB in non-PHT-exposed regions, the difference is not narrow enough to be utilized in guiding clinical decisions on the duration of PHT.


Corresponding author: Carlos Zozaya, MD, Neonatal Unit, Paediatric Service, Hospital Universitario de Getafe, Carretera Madrid – Toledo, Km 12,500, 28905 Getafe, Madrid, Spain

Acknowledgments

We would like to thank the Hospital of Getafe Neonatal Unit nurses, and Israel J. Thuissard Vasallo and David Sanz Rosa from the Statistical Department, for their valuable contribution to perform this study. We also appreciate Flora Shan (The Children’s Hospital of Winnipeg, Canada) for the revision of this manuscript.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  6. Financial disclosure: The authors declare no conflict of interest.

References

1. Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. N Engl J Med 2008;358:920–8.10.1056/NEJMct0708376Search in Google Scholar PubMed

2. Engle WD, Jackson GL, Engle NG. Transcutaneous bilirubinometry. Semin Perinatol 2014;38:438–51.10.1053/j.semperi.2014.08.007Search in Google Scholar PubMed

3. Fok TF, Lau SP, Hui CW, Fung KP, Wan CW. Transcutaneous bilirubinometer: its use in Chinese term infants and the effect of haematocrit and phototherapy on the TcB index. Aust Paediatr J 1986;22:107–9.10.1111/j.1440-1754.1986.tb00199.xSearch in Google Scholar PubMed

4. Yamanouchi I, Yamauchi Y, Igarashi I. Transcutaneous bilirubinometry: preliminary studies of noninvasive transcutaneous bilirubin meter in the Okayama National Hospital. Pediatrics 1980;65:195.10.1542/peds.65.2.195Search in Google Scholar

5. Galletto P, Vignolo Lutati C, Farina D, Gavinelli R. [Supervision of neonatal jaundice by use of the transcutaneous bilirubinometer]. Minerva Pediatr 1983;35:51–5.Search in Google Scholar

6. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316.10.1542/peds.114.1.297Search in Google Scholar PubMed

7. Domínguez Ortega F, Ormazábal Ramos JC, Martín Zarza M, Domenech Martínez E. [Transcutaneous bilirubinometry: correlation of the reading site obtained with spectrophotometry and diazoreaction technique]. An Esp Pediatr 1993;39:438–40.Search in Google Scholar

8. Kumar A, Faridi MM, Singh N, Ahmad SH. Transcutaneous bilirubinometry in the management of bilirubinemia in term neonates. Indian J Med Res 1994;99:227–30.Search in Google Scholar

9. Tan KL, Dong F. Transcutaneous bilirubinometry during and after phototherapy. Acta Paediatr 2003;92:327–31.10.1111/j.1651-2227.2003.tb00554.xSearch in Google Scholar

10. Mahajan G, Kaushal RK, Sankhyan N, Sharma RL, Nakra M. Transcutaneous bilirubinometer in assessment of neonatal jaundice in northern India. Indian Pediatr 2005;42:41–5.Search in Google Scholar

11. Zecca E, Barone G, De Luca D, Marra R, Tiberi E, Romagnoli C. Skin bilirubin measurement during phototherapy in preterm and term newborn infants. Early Hum Dev 2009;85:537–40.10.1016/j.earlhumdev.2009.05.010Search in Google Scholar PubMed

12. Nagar G, Vandermeer B, Campbell S, Kumar M. Effect of phototherapy on the reliability of transcutaneous bilirubin devices in term and near-term infants: a systematic review and meta-analysis. Neonatology 2016;109:203–12.10.1159/000442195Search in Google Scholar PubMed

13. Rodríguez-Miguélez JM. Ictericia neonatal. In: Vento M, Moro M, editors. De guardia en Neonatología Protocolos y procedimientos de los cuidados neonatales Ergon, 2008: 575–86.Search in Google Scholar

14. Radfar M, Hashemieh M, Shirvani F, Madani R. Transcutaneous bilirubinometry in preterm and term newborn infants before and during phototherapy. Arch Iran Med 2016;19:323–8.Search in Google Scholar

15. Jnah A, Newberry DM, Eisenbeisz E. Comparison of transcutaneous and serum Bilirubin measurements in neonates 30 to 34 weeks’ gestation before, during, and after phototherapy. Adv Neonatal Care 2018;18:144–53.10.1097/ANC.0000000000000469Search in Google Scholar PubMed

16. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Int J Nurs Stud 2010;47:931–6.10.1016/j.ijnurstu.2009.10.001Search in Google Scholar

17. Pendse A, Jasani B, Nanavati R, Kabra N. Comparison of transcutaneous bilirubin measurement with total serum bilirubin levels in preterm neonates receiving phototherapy. Indian Pediatr 2017;54:641–3.10.1007/s13312-017-1126-ySearch in Google Scholar PubMed

18. Murli L, Thukral A, Sankar MJ, Vishnubhatla S, Deorari AK, Paul VK, et al. Reliability of transcutaneous bilirubinometry from shielded skin in neonates receiving phototherapy: a prospective cohort study. J Perinatol 2017;37:182–7.10.1038/jp.2016.189Search in Google Scholar PubMed

19. Knudsen A, Ebbesen F. Cephalocaudal progression of jaundice in newborns admitted to neonatal intensive care units. Biol Neonate 1997;71:357–61.10.1159/000244436Search in Google Scholar PubMed

Received: 2018-12-23
Accepted: 2019-03-26
Published Online: 2019-04-18
Published in Print: 2019-07-26

©2019 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Preterm premature rupture of membranes (PPROM)
  4. Original Articles – Obstetrics
  5. The value of amniotic fluid analysis in patients with suspected clinical chorioamnionitis
  6. Patients with acute cervical insufficiency without intra-amniotic infection/inflammation treated with cerclage have a good prognosis
  7. Maternal serum endocan concentrations are elevated in patients with preterm premature rupture of membranes
  8. The earlier the gestational age, the greater the intensity of the intra-amniotic inflammatory response in women with preterm premature rupture of membranes and amniotic fluid infection by Ureaplasma species
  9. Assessment of maternal GBS colonization and early-onset neonatal disease rate for term deliveries: a decade perspective
  10. Clinical importance of the 75-g glucose tolerance test (GTT) in the prediction of large for gestational age (LGA) fetuses in non-diabetic pregnancies
  11. Expression of genes involved in inflammation and growth – does sampling site in human full-term placenta matter?
  12. Impact of cell-free fetal DNA on invasive prenatal diagnostic tests in a real-world public setting
  13. Perinatal outcome in gestational diabetes according to different diagnostic criteria
  14. Original Articles – Fetus
  15. Change in fetal behavior in response to vibroacoustic stimulation
  16. Diagnostic accuracy of isolated clubfoot in twin compared to singleton gestations
  17. Original Article – Newborn
  18. Usefulness of transcutaneous bilirubin assessment measured in non-photo-exposed skin to guide the length of phototherapy: an observational study
  19. Letters to the Editor
  20. Methodological issues on the clinical importance of the 75-g glucose tolerance test (GTT) in the prediction of large for gestational age (LGA) fetuses in non-diabetic pregnancies
  21. Reply to the Letter to the Editor: methodological issues on the clinical importance of the 75-g glucose tolerance test (GTT) in the prediction of large-for-gestational-age (LGA) fetuses in non-diabetic pregnancies
Downloaded on 7.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpm-2018-0429/html
Scroll to top button